Alpha Teknova, Inc.
About Alpha Teknova, Inc.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $40.5M
- Net income
- -$17.3M
- Total assets
- $103.6M
- Market cap
- $244.5M
- Gross margin
- 33.2%
- Operating margin
- -41.9%
- Net margin
- -42.6%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $40.5M
- Cost of revenue
- $27.1M
- Gross profit
- $13.4M
- Operating expenses
- $30.4M
- Operating income
- -$17.0M
- Income tax
- $58.0K
- Net income
- -$17.3M
- EPS (basic)
- $-0.32
- EPS (diluted)
- $-0.32
Balance sheet
- Total assets
- $103.6M
- Current assets
- $34.5M
- Total liabilities
- $34.8M
- Current liabilities
- $7.5M
- Shareholders’ equity
- $68.8M
Cash flow
- Operating cash flow
- -$8.6M
- Investing cash flow
- $10.7M
- Financing cash flow
- $151.0K
- Net cash flow
- $2.2M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $244.5M
- EPS (diluted)
- $-0.32
- Shares outstanding
- 52.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 25, 2021
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $17.3M in FY2025.
- Revenue grew 10% from FY2021 to FY2025.
- Gross margin of 33.2%, net margin -42.6%.
- Trading 34% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Alpha Teknova, Inc..
Write a review
News about Alpha Teknova, Inc.
News & sentiment via Polygon.io
